ECG alterations associated with psychotropic drug use in clinical settings: clinical and genetic predictors

Chiara Fabbri; Giuseppe Boriani; Igor Diemberger; Massimo Filippi; Gloria Ravegnini; Patrizia Hrelia; Alessandro Minarini; Diego Albani; Gianluigi Forloni; Sabrina Angelini; Alessandro Serretti

doi:10.1016/s0924-977x(16)31106-3

Related publications

Article2016

Clinical Significance of Epigenetic Alterations in Human Hepatocellular Carcinoma and Its Association with Genetic Mutations

Naoshi Nishida, Masatoshi Kudo

Article2008

Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study

Renate B. Schnabel, Josée Dupuis, Martin G. Larson, Kathryn L. Lunetta, Sander J. Robins, Yanyan Zhu, Jian Rong, Xiaoyan Yin, Heide A. Stirnadel, Jeanne J. Nelson, Peter W.F. Wilson, John F. Keaney, Ramachandran S. Vasan, Emelia Benjamin

Article2014

4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents

Masanori Taniwaki, Giulio Stefanini, Sigmund Silber, Gert Richardt, Pascal Vranckx, Patrick W. Serruys, Paweł Buszman, Henning Kelbæk, Stephan Windecker

Journal of the American College of Cardiology

Article2013

Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide‐based regimens

Tina Bagratuni, Efstathios Kastritis, Marianna Politou, Μαρία Ρούσσου, Efthimios Kostouros, Maria Gavriatopoulou, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Kanelias, Evangelos Terpos, Meletios A Dimopoulos

Article2009

Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: A review of published data

Giannis Mountzios, Meletios A Dimopoulos, Jean‐Charles Soria, Despina Sanoudou, Christos Papadimitriou